| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/25/1996 | CA2194773A1 Method and compound for the treatment of hair loss |
| 01/25/1996 | CA2194702A1 Conformationally rigid bicyclic and adamantane derivatives useful as .alpha.2-adrenergic blocking agents |
| 01/25/1996 | CA2194550A1 Invariant chain compositions useful for treating autoimmune diseases |
| 01/25/1996 | CA2194548A1 Proinsulin peptide compounds for detecting and treating type i diabetes |
| 01/24/1996 | EP0693489A1 Heterocyclic tachykinin receptor antagonists |
| 01/24/1996 | EP0693285A2 Pharmaceutical compositions containing a bisphosphonate and an anti-resorptive agent for inhibiting bone loss |
| 01/24/1996 | EP0692971A1 Analogs of peptide yy and uses thereof |
| 01/24/1996 | EP0692965A1 Method and composition for treatment of osteoporosis |
| 01/24/1996 | EP0513285B1 Imidazol-2-yl derivatives of substituted bicyclic compounds and process for their preparation |
| 01/24/1996 | EP0451216B1 Humanized immunoglobulins and their production and use |
| 01/23/1996 | CA2154414A1 Combination treatment for inhibiting bone loss |
| 01/23/1996 | CA1337991C Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds |
| 01/18/1996 | WO1996001430A2 Screening for nuc inhibitors |
| 01/18/1996 | WO1996001316A1 NOVEL GROWTH OR DIFFERENTIATION FACTOR OF THE TGF-β FAMILY |
| 01/18/1996 | WO1996001275A1 O-glycosylated authentic igf-i and truncated variants thereof, a method of preparation thereof and pharmaceutical compositions |
| 01/18/1996 | WO1996001270A1 Human elastase iv |
| 01/18/1996 | WO1996001253A2 Pla2 inhibitors and their use for inhibition of intestinal cholesterol absorption |
| 01/18/1996 | WO1996001124A1 Use of igf-i or analogues thereof in the prevention of diabetes |
| 01/18/1996 | WO1996001115A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 01/18/1996 | DE4424678A1 Dioxo-thiopyrano-pyridin-carbonsäure-derivate Dioxo-thiopyrano-pyridine-carboxylic acid derivatives |
| 01/18/1996 | CA2194403A1 Use of igf-i or analogues thereof in the prevention of diabetes |
| 01/18/1996 | CA2194391A1 Human elastase iv |
| 01/18/1996 | CA2193685A1 Screening for nuc inhibitors |
| 01/18/1996 | CA2193399A1 O-glycosylated authentic igf-i and truncated variants thereof, a method of preparation thereof and pharmaceutical compositions |
| 01/18/1996 | CA2191775A1 Pla2 inhibitors and their use for inhibition of intestinal cholesterol absorption |
| 01/17/1996 | EP0692457A2 A hexagonal molecular structure water manufacturing apparatus and a method thereof |
| 01/17/1996 | EP0691844A1 Method for treating amyloidosis |
| 01/17/1996 | EP0691814A1 Method and composition for treatment of osteoporosis |
| 01/17/1996 | EP0635014B1 Indole derivatives as 5-ht1-like agonists |
| 01/17/1996 | EP0554381B1 Use of protective agents against reactive oxygen species |
| 01/17/1996 | CN1114880A Novel treatment |
| 01/17/1996 | CN1030718C Superoxide dismutase |
| 01/16/1996 | US5484810 Tissue protective tocopherol analogs |
| 01/16/1996 | US5484798 Benzothiopene compounds, compositions, and method of inhibiting restenosis |
| 01/16/1996 | US5484797 Naphthly compounds, intermediates, processes, compositions, and method for inhibiting endometrosis |
| 01/16/1996 | US5484796 Naphthyl compounds, intermediates, processes, compositions, and method of inhibiting aortal smooth muscle cell proliferation |
| 01/16/1996 | US5484795 Naphthyl compounds, intermediates, processes, compositions, and method of inhibiting restenosis |
| 01/16/1996 | US5484783 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives |
| 01/16/1996 | CA1337930C Method of treating skin injuries using thromboxane a__ receptor antagonists |
| 01/11/1996 | WO1996000738A1 Endothelin antagonists ii |
| 01/11/1996 | WO1996000732A1 Phosphinic acid derivatives |
| 01/11/1996 | WO1996000587A1 Aav capsid vehicles for molecular transfer |
| 01/11/1996 | WO1996000574A1 Vitronectin receptor antagonists |
| 01/11/1996 | CA2193802A1 Aav capsid vehicles for molecular transfer |
| 01/11/1996 | CA2190756A1 Endothelin antagonists ii |
| 01/10/1996 | EP0691129A2 Thiazolidone and pyrrolidinone compounds for inhibiting bone loss |
| 01/10/1996 | EP0691128A1 Methods of administering CRF antagonists |
| 01/10/1996 | EP0691079A2 Enteral composition for diabetic patients |
| 01/10/1996 | EP0690872A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/10/1996 | EP0690719A1 Dry mix formulation for bisphosphonic acids |
| 01/10/1996 | EP0600949B1 New 3,5-di-tert.butyl-4-hydroxyphenyl derivatives, methods of preparing them and drugs containing them |
| 01/10/1996 | EP0543018B1 Antidiabetic agent |
| 01/10/1996 | EP0495879B1 Compositions and methods for weight reduction |
| 01/10/1996 | EP0394429B1 Preparation for transdermal application containing gestodene |
| 01/09/1996 | US5482958 Method for treating endometriosis |
| 01/09/1996 | US5482950 Methods for lowering serum cholesterol |
| 01/09/1996 | US5482949 Inhibiting bone loss, lowering cholesterol levels, and treating estrogen dependent mammary or uterine carcinoma |
| 01/09/1996 | US5482944 Administering to alleviate tumor necrosis factor-related disorders |
| 01/09/1996 | US5482926 Growth factor IGF-Il |
| 01/09/1996 | US5482712 Galenic composition |
| 01/07/1996 | CA2153213A1 Methods of inhibiting bone loss |
| 01/04/1996 | WO1996000288A2 Class bi and ci scavenger receptors |
| 01/04/1996 | WO1996000086A1 Therapeutic method and remedy for diabetes |
| 01/04/1996 | CA2193832A1 Class bi and ci scavenger receptors |
| 01/03/1996 | EP0689837A2 Anti-hyperglycemic medicaments |
| 01/03/1996 | EP0689588A1 Extracellular signal-regulated kinase, sequences, and methods of production and use |
| 01/03/1996 | EP0689443A1 The use of bisphosphonates in bone surgery |
| 01/03/1996 | EP0553130B1 Pyrrolidine dione derivatives |
| 01/03/1996 | EP0473701B1 Recombinant dna method for production of parathyroid hormone |
| 01/03/1996 | EP0462292B1 Salt eliminant composition |
| 01/03/1996 | CN1114312A Sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation, and their use as pharmaceuticals |
| 01/03/1996 | CN1114310A 1H-indole-3-glyoxylamide spla2 inhibitors |
| 01/03/1996 | CN1030609C Methylenebisphosphonic acid derivatives |
| 01/02/1996 | US5480999 Containing an acid and an arginine analogue |
| 01/02/1996 | US5480910 Chemical compounds |
| 01/02/1996 | US5480891 Method for treating diabetes mellitus |
| 01/02/1996 | US5480873 Arthritis |
| 01/02/1996 | US5480867 Glucagon analogs with serine replacements |
| 01/02/1996 | CA1337891C Anf derivatives with novel bridging |
| 12/28/1995 | WO1995035314A1 Thiazolidine derivatives, their preparation and drugs containing same |
| 12/28/1995 | WO1995035303A1 Synthesis of conduritol epoxides and aziridines and methods of using such to synthesize higher disaccharides |
| 12/28/1995 | WO1995035294A1 Protein kinase c inhibitors |
| 12/28/1995 | WO1995035277A1 Substituted azetidinone compounds useful as hypocholesterolemic agents |
| 12/28/1995 | WO1995035116A1 Hgh containing pharmaceutical compositions |
| 12/28/1995 | WO1995035110A1 Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders |
| 12/28/1995 | WO1995027495A3 Treatment of partial growth hormone insensitivity syndrome |
| 12/28/1995 | CA2193530A1 Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders |
| 12/28/1995 | CA2191455A1 Substituted azetidinone compounds useful as hypocholesterolemic agents |
| 12/27/1995 | EP0688866A1 Thermostable trehalose-releasing enzyme, and its preparation and uses |
| 12/27/1995 | EP0688787A1 Medicinal composition for bone resorption inhibition and osteogenesis acceleration |
| 12/27/1995 | EP0688761A2 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses |
| 12/27/1995 | EP0688365A1 Fertility regulation with transforming growth factor beta |
| 12/27/1995 | EP0688325A1 Phosphonic acid derivatives |
| 12/27/1995 | EP0688211A1 Methods and compositions for inhibition of angiogenesis |
| 12/27/1995 | EP0584159B1 Nutrient preparation |
| 12/27/1995 | EP0542864B1 Use of phospholipids for the manufacture of a topical medicament for modifying serum cholesterol levels |
| 12/27/1995 | EP0471811B1 Allosteric hemoglobin modifiers |
| 12/27/1995 | CN1113911A Therapuetic agents |
| 12/26/1995 | US5478955 26,27-dimethylene-1α,25-dihydroxyvitamin D2 and 26, 27-dimethylene-24-epi-1α, 25-dihydroxyvitamin D2 and methods for preparing same |
| 12/26/1995 | US5478852 Administering |